The article focuses on the vote of the French National Assembly on May 31, 2010 for maintaining the prohibition on the use for research of the human embryo and embryonic stem cells except for drug testing and diagnosis. It mentions that the second revision to the 1994 bioethics law in France has been revised in 2001 that led to intense debates. It also notes the uncertainty and problems on securing funding for scientists who will be working under a prohibition exemption.